Volunteers are the heart of Rally's mission!
Rally Foundation’s Advocacy
Your voice matters and here’s proof:
$317.5 Million
Rally Foundation leads the charge for funding from the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP). In eight years, our collective voices have secured $317.5 million for cancers that affect children, adolescents and young adults resulting in 269 new federally-funded research projects.
Helpful Submission Tips and Insights
Rally hosted a webinar with Julie Huiberts, PRCRP Program Manager. Ms. Huiberts provided expert insights and best practices for completing and submitting your DOD grant application. You can access the webinar video recording and presentation slides below.
Rally’s DOD Efforts Since 2017
DOD Peer Reviewed Cancer Research Program (PRCRP)
| YEAR | PRCRP BUDGET | # OF ELIGIBLE CATEGORIES (CANCERS) | PEDIATRIC & AYA CANCERS | PEDIATRIC BRAIN TUMORS | NEUROBLASTOMA | TOTAL OF PRCRP BUDGET |
|---|---|---|---|---|---|---|
| 2024* | $130M | 18 | $63.8M 28 Awards |
$2.6M 3 Awards |
$9.4M 11 Awards |
$75.8M |
| 2023 | $130M | 20 | $57M 42 Awards |
$10.2M 8 Awards |
$3.9M 3 Awards |
$67.4M |
| 2022 | $130M | 20 | $50.9M 44 Awards |
$4.8M 5 Awards |
$0.6M 1 Award |
$41.25M |
| 2021 | $130M | 20 | $46.1M 36 Awards |
$3.4M 3 Awards |
$6.5M 5 Awards |
$56M |
| 2020 | $110M | 14 | $10.8M 12 Awards |
$6.05M 7 Awards |
$4.8M 3 Awards |
$21.65M |
| 2019 | $90M | 15 | $7.5M 10 Awards |
$3.4M 5 Awards |
$4.9M 7 Awards |
$15.8M |
| 2018 | $80M | 17 | $6.5M 11 Awards |
$2.5M 3 Awards |
$1.7M 4 Awards |
$10.7M |
| 2017 | $60M | 14 | $3.1M 7 Awards |
$4.7M 8 Awards |
$2.4M 3 Awards |
$10.2M |
| Eight-Year Total | $245.7M | $37.65M | $34.2M | $317.55M | ||
* Rally Foundation is the lead advocate for funding to research cancers in pediatric, adolescent and young adult cancers, sarcoma, germ cell cancers, thyroid cancer and lymphoma.
* PAYA funding includes: pediatric, adolescent and young adult cancers, sarcoma, germ cell cancers, thyroid cancer, lymphoma and colorectal cancer.
* DOD will release quantity of awards upon completion of award negotiations.